Skip to content

Author

Y. Shirakami

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Limited impact of NLRP3 inflammasome deficiency on diet-induced metabolic dysfunction-associated steatohepatitis in mice

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD) and a growing cause of chronic liver disease worldwide. Although the NLRP3 inflammasome has been implicated in MASH pathogenesis, its contribution remains controversial acros...

Daisuke Taguchi, Y. Shirakami, Toshihide Maeda et al. · 0 citations
Open access Aug 2026

A 12-week home-based exercise program with nutritional guidance is associated with improved functional capacity in chronic liver disease.

BACKGROUND & AIMS Although exercise therapy improves physical function in chronic liver disease (CLD), structured programs remain underutilized in routine hepatology care. We evaluated the feasibility, safety, and potential functional impact of a structured home-based exercise program in patients with CLD. METHODS In...

S. Unome, Takao Miwa, Yoshihiko Atago et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.